Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancersAhmad Al‐Attar, Srinivasan Madhusudan, Lucy Gossage et al.|British Journal of Cancer|2010Cited by 111
Biomarkers of response to therapy in oesophago-gastric cancerKhaleel Fareed, Srinivasan Madhusudan, Philip Kaye et al.|Gut|2008Cited by 86
Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapyKhaleel Fareed, Srinivasan Madhusudan, Ahmad Al‐Attar et al.|British Journal of Cancer|2010Cited by 81
Tumour regression grade (TRG) analyses in patients with resectable gastro‐oesophageal adenocarcinomas treated with platinum‐based neoadjuvant chemotherapyKhaleel Fareed, Srinivasan Madhusudan, Mohammad Ilyas et al.|Histopathology|2009Cited by 44
Expression of key hypoxia sensing prolyl‐hydroxylases PHD1, ‐2 and ‐3 in pancreaticobiliary cancerLucy Gossage, Srinivasan Madhusudan, Abed M. Zaitoun et al.|Histopathology|2010Cited by 40